After rocketing higher on Friday following its initial public offering (IPO), the Singular Health Group Ltd (ASX: SHG) share price is doing it again on Monday.
In afternoon trade the 3D medical imaging company’s shares are up a further 26% to 48 cents.
This means the Singular Health share price is now up a massive 140% from its listing price of 20 cents.
Why is the Singular Health share price surging higher?
Investors appear to have been buying Singular Health shares due to excitement around the company’s technology.
Singular Health is a technology-driven medical imaging company with the aim of developing technologies that provide patients and practitioners with access to personalised, enhanced, medical data to inform better health decisions.
Its key solution is the Volumetric Rendering Platform. This platform uses proprietary code and algorithms to accurately convert traditional 2D medical imagery into volumetric 3D models.
Once this imagery has been converted into 3D models, users are able to visualise, manipulate, modify, and review the model using a standard monitor or by utilising virtual reality.
Management notes that its platform has several distinct advantages. It expects these advantages to drive adoption in the areas of surgical planning, medical education, and patient education.
What’s next?
Singular Health raised $6 million from its IPO. The proceeds will be used to execute its growth strategy, fund research and development, working capital, and for the purchase of a titanium 3D printer.
In respect to its growth strategy, management appears positive on the future.
It commented: “Singular Health has already established a strategy for the vertical integration of the Company’s capabilities, in collaboration with key opinion leaders and joint ventures with established businesses, to develop an end-to-end solution for the visualisation, analysis and segmentation via artificial intelligence and production of bespoke solutions through additive manufacturing.”
However, it is still early days. Furthermore, a significant amount of future growth is already being priced into Singular Health’s shares.
Based on the current Singular Health share price and its 102.2 million shares outstanding, the company has a market capitalisation of $49 million. This compares to financial year to date revenue of just $22,000.
This Tiny ASX Stock Could Be the Next Afterpay
One little-known Australian IPO has tripled in value since January 2020, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…
Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.
Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!
See how you can find out the name of this stock
Returns as of 15th February 2021
More reading
- Singular Health (ASX:SHG) share price rockets 100% higher following IPO
- Why Novonix, Recce, Singular Health, & Starpharma shares are storming higher
- Singular Health (ASX:SHG) shares arrive on the ASX
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post The Singular Health (ASX:SHG) share price is now up 140% since its IPO appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3dcWEqy
Leave a Reply